Are Direct Acting Oral Anticoagulants Ready for Prime-Time Use in Cancer-Related Thrombosis?

  H&O  How common is thrombosis in patients being treated for cancer? MS  Approximately 20% to 25% of patients with venous thromboembolism (VTE) at a typical […]